• Home
  • Pharmaceuticals and Healthcare
Drugs for Osteoarthritis Pain Market - Global Outlook and Forecast 2021-2027

Drugs for Osteoarthritis Pain Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ747851 | No. of Pages: 107 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: May-2021 
This report contains market size and forecasts of Drugs for Osteoarthritis Pain in Global, including the following market information:
Global Drugs for Osteoarthritis Pain Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Drugs for Osteoarthritis Pain market was valued at 8983.1 million in 2020 and is projected to reach US$ 11190 million by 2027, at a CAGR of 5.6% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Osteoarthritis Pain companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Osteoarthritis Pain Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Drugs for Osteoarthritis Pain Market Segment Percentages, By Type, 2020 (%)
Oral
Injection
External

China Drugs for Osteoarthritis Pain Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Drugs for Osteoarthritis Pain Market Segment Percentages, By Application, 2020 (%)
Medical Care
Personal Care

Global Drugs for Osteoarthritis Pain Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Drugs for Osteoarthritis Pain Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Drugs for Osteoarthritis Pain Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Drugs for Osteoarthritis Pain Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
1 Introduction to Research & Analysis Reports
    1.1 Drugs for Osteoarthritis Pain Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Drugs for Osteoarthritis Pain Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Drugs for Osteoarthritis Pain Overall Market Size
    2.1 Global Drugs for Osteoarthritis Pain Market Size: 2021 VS 2027
    2.2 Global Drugs for Osteoarthritis Pain Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Drugs for Osteoarthritis Pain Players in Global Market
    3.2 Top Global Drugs for Osteoarthritis Pain Companies Ranked by Revenue
    3.3 Global Drugs for Osteoarthritis Pain Revenue by Companies
    3.4 Top 3 and Top 5 Drugs for Osteoarthritis Pain Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Drugs for Osteoarthritis Pain Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Drugs for Osteoarthritis Pain Players in Global Market
        3.6.1 List of Global Tier 1 Drugs for Osteoarthritis Pain Companies
        3.6.2 List of Global Tier 2 and Tier 3 Drugs for Osteoarthritis Pain Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Drugs for Osteoarthritis Pain Market Size Markets, 2021 & 2027
        4.1.2 Oral
        4.1.3 Injection
        4.1.4 External
    4.2 By Type - Global Drugs for Osteoarthritis Pain Revenue & Forecasts
        4.2.1 By Type - Global Drugs for Osteoarthritis Pain Revenue, 2016-2021
        4.2.2 By Type - Global Drugs for Osteoarthritis Pain Revenue, 2022-2027
        4.2.3 By Type - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Drugs for Osteoarthritis Pain Market Size, 2021 & 2027
        5.1.2 Medical Care
        5.1.3 Personal Care
    5.2 By Application - Global Drugs for Osteoarthritis Pain Revenue & Forecasts
        5.2.1 By Application - Global Drugs for Osteoarthritis Pain Revenue, 2016-2021
        5.2.2 By Application - Global Drugs for Osteoarthritis Pain Revenue, 2022-2027
        5.2.3 By Application - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Drugs for Osteoarthritis Pain Market Size, 2021 & 2027
    6.2 By Region - Global Drugs for Osteoarthritis Pain Revenue & Forecasts
        6.2.1 By Region - Global Drugs for Osteoarthritis Pain Revenue, 2016-2021
        6.2.2 By Region - Global Drugs for Osteoarthritis Pain Revenue, 2022-2027
        6.2.3 By Region - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Drugs for Osteoarthritis Pain Revenue, 2016-2027
        6.3.2 US Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.3.3 Canada Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.3.4 Mexico Drugs for Osteoarthritis Pain Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Drugs for Osteoarthritis Pain Revenue, 2016-2027
        6.4.2 Germany Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.4.3 France Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.4.4 U.K. Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.4.5 Italy Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.4.6 Russia Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.4.7 Nordic Countries Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.4.8 Benelux Drugs for Osteoarthritis Pain Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Drugs for Osteoarthritis Pain Revenue, 2016-2027
        6.5.2 China Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.5.3 Japan Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.5.4 South Korea Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.5.5 Southeast Asia Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.5.6 India Drugs for Osteoarthritis Pain Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Drugs for Osteoarthritis Pain Revenue, 2016-2027
        6.6.2 Brazil Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.6.3 Argentina Drugs for Osteoarthritis Pain Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Drugs for Osteoarthritis Pain Revenue, 2016-2027
        6.7.2 Turkey Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.7.3 Israel Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.7.4 Saudi Arabia Drugs for Osteoarthritis Pain Market Size, 2016-2027
        6.7.5 UAE Drugs for Osteoarthritis Pain Market Size, 2016-2027
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Drugs for Osteoarthritis Pain Major Product Offerings
        7.1.4 Pfizer Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.1.5 Pfizer Key News
    7.2 Johnson & Johnson
        7.2.1 Johnson & Johnson Corporate Summary
        7.2.2 Johnson & Johnson Business Overview
        7.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Major Product Offerings
        7.2.4 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.2.5 Johnson & Johnson Key News
    7.3 GlaxoSmithKline
        7.3.1 GlaxoSmithKline Corporate Summary
        7.3.2 GlaxoSmithKline Business Overview
        7.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Major Product Offerings
        7.3.4 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.3.5 GlaxoSmithKline Key News
    7.4 Bayer
        7.4.1 Bayer Corporate Summary
        7.4.2 Bayer Business Overview
        7.4.3 Bayer Drugs for Osteoarthritis Pain Major Product Offerings
        7.4.4 Bayer Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.4.5 Bayer Key News
    7.5 Eli Lilly
        7.5.1 Eli Lilly Corporate Summary
        7.5.2 Eli Lilly Business Overview
        7.5.3 Eli Lilly Drugs for Osteoarthritis Pain Major Product Offerings
        7.5.4 Eli Lilly Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.5.5 Eli Lilly Key News
    7.6 Novartis
        7.6.1 Novartis Corporate Summary
        7.6.2 Novartis Business Overview
        7.6.3 Novartis Drugs for Osteoarthritis Pain Major Product Offerings
        7.6.4 Novartis Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.6.5 Novartis Key News
    7.7 Sanofi
        7.7.1 Sanofi Corporate Summary
        7.7.2 Sanofi Business Overview
        7.7.3 Sanofi Drugs for Osteoarthritis Pain Major Product Offerings
        7.4.4 Sanofi Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.7.5 Sanofi Key News
    7.8 Horizon Pharma
        7.8.1 Horizon Pharma Corporate Summary
        7.8.2 Horizon Pharma Business Overview
        7.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Major Product Offerings
        7.8.4 Horizon Pharma Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.8.5 Horizon Pharma Key News
    7.9 Abbott
        7.9.1 Abbott Corporate Summary
        7.9.2 Abbott Business Overview
        7.9.3 Abbott Drugs for Osteoarthritis Pain Major Product Offerings
        7.9.4 Abbott Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.9.5 Abbott Key News
    7.10 Mylan
        7.10.1 Mylan Corporate Summary
        7.10.2 Mylan Business Overview
        7.10.3 Mylan Drugs for Osteoarthritis Pain Major Product Offerings
        7.10.4 Mylan Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.10.5 Mylan Key News
    7.11 Daiichi Sankyo
        7.11.1 Daiichi Sankyo Corporate Summary
        7.11.2 Daiichi Sankyo Business Overview
        7.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Major Product Offerings
        7.11.4 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.11.5 Daiichi Sankyo Key News
    7.12 TEVA
        7.12.1 TEVA Corporate Summary
        7.12.2 TEVA Business Overview
        7.12.3 TEVA Drugs for Osteoarthritis Pain Major Product Offerings
        7.12.4 TEVA Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.12.5 TEVA Key News
    7.13 Almatica Pharma
        7.13.1 Almatica Pharma Corporate Summary
        7.13.2 Almatica Pharma Business Overview
        7.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Major Product Offerings
        7.13.4 Almatica Pharma Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.13.5 Almatica Pharma Key News
    7.14 Astellas Pharma
        7.14.1 Astellas Pharma Corporate Summary
        7.14.2 Astellas Pharma Business Overview
        7.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Major Product Offerings
        7.14.4 Astellas Pharma Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.14.5 Astellas Pharma Key News
    7.15 Tide Pharmaceutical
        7.15.1 Tide Pharmaceutical Corporate Summary
        7.15.2 Tide Pharmaceutical Business Overview
        7.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Major Product Offerings
        7.15.4 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.15.5 Tide Pharmaceutical Key News
    7.16 Iroko Pharmaceuticals
        7.16.1 Iroko Pharmaceuticals Corporate Summary
        7.16.2 Iroko Pharmaceuticals Business Overview
        7.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Major Product Offerings
        7.16.4 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.16.5 Iroko Pharmaceuticals Key News
    7.17 Hengrui Pharmaceutical
        7.17.1 Hengrui Pharmaceutical Corporate Summary
        7.17.2 Hengrui Pharmaceutical Business Overview
        7.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Major Product Offerings
        7.17.4 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.17.5 Hengrui Pharmaceutical Key News
    7.18 Abiogen Pharma
        7.18.1 Abiogen Pharma Corporate Summary
        7.18.2 Abiogen Pharma Business Overview
        7.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Major Product Offerings
        7.18.4 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
        7.18.5 Abiogen Pharma Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com